Aveanna Healthcare (NASDAQ:AVAH) CAO Deborah Stewart Sells 11,275 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) CAO Deborah Stewart sold 11,275 shares of Aveanna Healthcare stock in a transaction on Wednesday, December 31st. The shares were sold at an average price of $8.18, for a total transaction of $92,229.50. Following the completion of the sale, the chief accounting officer directly owned 263,638 shares of the company’s stock, valued at approximately $2,156,558.84. This trade represents a 4.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Deborah Stewart also recently made the following trade(s):

• On Friday, January 2nd, Deborah Stewart sold 11,962 shares of Aveanna Healthcare stock. The stock was sold at an average price of $7.85, for a total transaction of $93,901.70.
• On Tuesday, December 30th, Deborah Stewart sold 11,379 shares of Aveanna Healthcare stock. The shares were sold at an average price of $8.36, for a total value of $95,128.44.

Aveanna Healthcare Stock Down 1.1%

AVAH stock opened at $8.08 on Friday. The stock’s 50 day simple moving average is $8.92 and its 200 day simple moving average is $7.49. The company has a market cap of $1.69 billion, a P/E ratio of 22.44 and a beta of 2.06. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a fifty-two week low of $3.67 and a fifty-two week high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Monday, May 22nd. The company reported $0.04 EPS for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The firm had revenue of $450.53 million during the quarter. On average, research analysts expect that Aveanna Healthcare Holdings Inc. will post -0.06 earnings per share for the current fiscal year.

Key Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Hedge Funds Weigh In On Aveanna Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in AVAH. Jump Financial LLC purchased a new position in shares of Aveanna Healthcare in the 1st quarter worth about $59,000. Walleye Capital LLC raised its position in Aveanna Healthcare by 268.9% in the first quarter. Walleye Capital LLC now owns 51,470 shares of the company’s stock worth $279,000 after acquiring an additional 37,517 shares during the period. MetLife Investment Management LLC raised its position in Aveanna Healthcare by 16.2% in the first quarter. MetLife Investment Management LLC now owns 31,251 shares of the company’s stock worth $169,000 after acquiring an additional 4,349 shares during the period. AQR Capital Management LLC boosted its stake in Aveanna Healthcare by 21.2% in the first quarter. AQR Capital Management LLC now owns 26,280 shares of the company’s stock valued at $142,000 after acquiring an additional 4,602 shares during the last quarter. Finally, Banque Transatlantique SA bought a new position in shares of Aveanna Healthcare during the 1st quarter valued at approximately $25,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. BMO Capital Markets initiated coverage on shares of Aveanna Healthcare in a research note on Thursday, November 13th. They issued an “outperform” rating and a $11.00 price objective on the stock. William Blair began coverage on Aveanna Healthcare in a research report on Monday, December 8th. They set an “outperform” rating on the stock. JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price target for the stock from $6.00 to $10.00 in a report on Thursday, September 18th. UBS Group raised their price objective on Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research note on Friday, November 7th. Finally, Raymond James Financial reaffirmed an “outperform” rating and set a $13.00 price objective on shares of Aveanna Healthcare in a report on Friday, December 5th. Five analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $10.69.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.